Fortress Biotech, Inc. (NASDAQ:FBIOP) Short Interest Update

Fortress Biotech, Inc. (NASDAQ:FBIOP) saw a significant increase in short interest in July. As of July 31st, there was short interest totalling 8,000 shares, an increase of 1,042.9% from the July 15th total of 700 shares. Based on an average daily trading volume, of 20,200 shares, the short-interest ratio is presently 0.4 days.

Fortress Biotech Stock Down 0.8 %

NASDAQ FBIOP opened at $6.87 on Wednesday. The business has a 50 day moving average price of $11.75 and a 200 day moving average price of $14.24. Fortress Biotech has a 1-year low of $6.40 and a 1-year high of $18.00.

Fortress Biotech Announces Dividend

The company also recently declared a monthly dividend, which was paid on Sunday, June 30th. Stockholders of record on Saturday, June 15th were given a $0.1953 dividend. This represents a $2.34 dividend on an annualized basis and a dividend yield of 34.12%. The ex-dividend date was Friday, June 14th.

About Fortress Biotech

Fortress Biotech, Inc, a biopharmaceutical company, develops dermatology, pharmaceutical, and biotechnology products in the United States. The company markets dermatology products, such as Qbrexza a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane capsules for severe recalcitrant nodular acne; Amzeeq for severe acne vulgaris; Zilxi, a topical foam; Exelderm cream and solution for topical use; Targadox an oral doxycycline drug for adjunctive therapy for severe acne; Luxamend; sulconazole nitrate cream and solution for tinea cruris and tinea corporis; and doxycycline hyclate tablet.